Home/Filings/4/0001225208-24-003047
4//SEC Filing

BOSHOFF CHRISTOFFEL 4

Accession 0001225208-24-003047

CIK 0000078003other

Filed

Feb 26, 7:00 PM ET

Accepted

Feb 27, 1:44 PM ET

Size

18.7 KB

Accession

0001225208-24-003047

Insider Transaction Report

Form 4
Period: 2024-02-23
BOSHOFF CHRISTOFFEL
President, R&D
Transactions
  • Exercise/Conversion

    Common Stock

    2024-02-23$27.34/sh+9,752$266,620148,703 total
  • Tax Payment

    Common Stock

    2024-02-23$27.76/sh458$12,714148,245 total
  • Tax Payment

    Common Stock

    2024-02-23$27.76/sh675$18,738147,570 total
  • Tax Payment

    Common Stock

    2024-02-23$27.37/sh7,881$215,703139,689 total
  • Tax Payment

    Common Stock

    2024-02-24$27.76/sh300$8,328139,389 total
  • Award

    Common Stock

    2024-02-25+15,455154,844 total
  • Tax Payment

    Common Stock

    2024-02-25$27.76/sh1,403$38,947153,441 total
  • Tax Payment

    Common Stock

    2024-02-25$27.76/sh4,794$133,081148,647 total
  • Exercise/Conversion

    Stock Appreciation Rights

    2024-02-239,7520 total
    Exercise: $27.34From: 2024-02-23Exp: 2024-02-23Common Stock (9,752 underlying)
Holdings
  • Common Stock

    (indirect: By Rule 16b-3 Plan)
    624
Footnotes (8)
  • [F1]The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
  • [F2]The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon).
  • [F3]The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.
  • [F4]The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).
  • [F5]Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.
  • [F6]Price is the closing price of Pfizer common stock on February 23, 2024.
  • [F7]The reported transaction constitutes the earn-out of performance share awards (including dividend equivalents thereon).
  • [F8]The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the earn-out of performance share awards (including dividend equivalents thereon).

Documents

1 file

Issuer

PFIZER INC

CIK 0000078003

Entity typeother

Related Parties

1
  • filerCIK 0001988687

Filing Metadata

Form type
4
Filed
Feb 26, 7:00 PM ET
Accepted
Feb 27, 1:44 PM ET
Size
18.7 KB